Skip to content
TRJ-00 / HYPOTHESIS

Feed the world.
Without poisoning it.

Trajectory Bio is building the next generation of antifungals — derived from nature, safe for humans, and effective enough to replace the chemistries quietly making us sick.

Partner with us → Read the science
01 / The Urgency Fig. 01 — Risk surface

A quiet crisis
on every plate.

Fungi destroy enough food each year to feed hundreds of millions of people. The chemistries we use to fight them — many of them decades old — are now turning up in our soil, our water, and our bloodstreams.

Studies are linking long-term fungicide exposure to Parkinson's, kidney disease, endocrine disruption, and the rise of antifungal-resistant infections in humans.

We're losing food. We're losing health. And we're running out of safe tools.

S-01
~30%
of global crop yield lost to fungal disease each year.
S-02
20+
active fungicides under regulatory review for human safety.
S-03
5×
rise in azole-resistant fungal infections in the last decade.
02 / Why Now Fig. 02 — Origin & mechanism

Nature solved this problem first.

We didn't invent our compound. We found it.

Trajectory Bio is built around a naturally occurring molecule — discovered through foundational research at the National Research Council of Canada — that stops fungal growth at its source.

It's selective. It's biodegradable. It works at agricultural scale. And it does what synthetic fungicides do, without the collateral damage to the people eating the crop.

▸ The patent is ours. ▸ The science is proven. ▸ The window is now.
03 / The Solution Fig. 03 — Pillars

Green chemistry.
With teeth.

We're not asking growers to choose between yield and safety. We're ending the trade-off.

We're built to license — to the agricultural majors who already have the distribution, and the obligation, to make agriculture safer.

P-01

Effective

Performance benchmarked against the leading synthetics — without the toxicity profile.

P-02

Affordable

A production pathway designed from day one for cost parity with conventional fungicides.

P-03

Defensible

Composition-of-matter IP acquired from Canada's NRC, with a clear runway for global filings.

P-04

Safe by design

Naturally occurring. Biodegradable. Non-bioaccumulative.

04 / The Team Fig. 04 — Operators

Builders. Chemists.
Physicians.

One mission. Decades of compounded expertise across translational science, regulatory pathways, and global operations.

M-01

Francisco Díaz-Mitoma Jr.

Founder & CEO

Serial founder with previous experience in life sciences. Forbes 30 Under 30. Founder of healthtech company Bowhead Health, a Mayo Clinic Platform_Accelerate portfolio company and working with Top 10 pharma.

M-02

Dr. Ian Schoenhofen, PhD

Chief Scientist

Carbohydrate and natural-product chemist. 20+ years at the National Research Council of Canada. Inventor on the foundational chemistry powering Trajectory.

M-03

Dr. Francisco J. Díaz-Mitoma, MD, PhD

Chairman

Physician-scientist, vaccine developer, and biotech founder. Translating breakthrough biology into approved products for three decades.

05 / Contact Fig. 05 — Trajectory

The next chemistry of agriculture is being written now.

We're talking with crop science majors, family offices, and mission-aligned investors who understand that the global fungicide market is overdue for replacement — and that the molecule that replaces it has to come from somewhere.

It's coming from us.